PEP is a short-term antiretroviral treatment designed to prevent HIV infection after a potential exposure. It is typically prescribed for individuals who may have been exposed to HIV through unprotected sexual intercourse, sharing needles, or other high-risk activities. PEP consists of a 28-day course of medication, and its success in preventing HIV largely hinges on prompt initiation.
